Women who use drugs: engagement in practices of harm reduction care.
Canada
Care
Care ethics
Gendered labour
Harm reduction
Overdose
Substance use
Women
Journal
Harm reduction journal
ISSN: 1477-7517
Titre abrégé: Harm Reduct J
Pays: England
ID NLM: 101153624
Informations de publication
Date de publication:
13 04 2023
13 04 2023
Historique:
received:
16
11
2022
accepted:
28
03
2023
medline:
17
4
2023
entrez:
13
4
2023
pubmed:
14
4
2023
Statut:
epublish
Résumé
Harm reduction services that employ or are operated by people who use drugs are an effective means of mitigating overdose risks and other drug-related harms. However, stereotypes portraying people who use criminalized drugs as incapable caregivers persist. This is especially true for women who use drugs, and to a greater extent racialized women, who are characterized as having diverged from traditional ideals of womanhood as a result of drug-user stigma and the intersections of gender- and class-based and racist stereotypes. In an effort to identify and understand how women who use drugs practise care through harm reduction, we explored the experiences of women accessing a low-threshold supervised consumption site exclusively for women (transgender and non-binary inclusive) in Vancouver, Canada. Data were drawn from research conducted from May 2017 to June 2018 exploring women's experiences accessing the supervised consumption site during an overdose crisis. Data included forty-five semistructured interviews with women recruited from the site, analysed thematically to explore practices of care through harm reduction. Participants reported engaging in both formal and informal care. Acts of care included interventions that both aligned with and deviated from conventional understandings of care practices, including overdose reversal and education, overdose supervision/care, and assisted injection. The boundary between formal and informal harm reduction care is fluid. Women who use drugs engage in harm reduction across these borders with acts of care that align with or fill the gaps in current harm reduction services in order to meet the needs of drug-using communities, challenging negative stereotypes of women who use drugs. However, these caregiving practices can increase risks to care providers' physical, mental, and emotional health and wellness. Increased financial, social, and institutional supports, including safer supply, assisted injection, and community resources, are needed to better support women as they continue to engage in harm reduction care.
Sections du résumé
BACKGROUND
Harm reduction services that employ or are operated by people who use drugs are an effective means of mitigating overdose risks and other drug-related harms. However, stereotypes portraying people who use criminalized drugs as incapable caregivers persist. This is especially true for women who use drugs, and to a greater extent racialized women, who are characterized as having diverged from traditional ideals of womanhood as a result of drug-user stigma and the intersections of gender- and class-based and racist stereotypes. In an effort to identify and understand how women who use drugs practise care through harm reduction, we explored the experiences of women accessing a low-threshold supervised consumption site exclusively for women (transgender and non-binary inclusive) in Vancouver, Canada.
METHODS
Data were drawn from research conducted from May 2017 to June 2018 exploring women's experiences accessing the supervised consumption site during an overdose crisis. Data included forty-five semistructured interviews with women recruited from the site, analysed thematically to explore practices of care through harm reduction.
FINDINGS
Participants reported engaging in both formal and informal care. Acts of care included interventions that both aligned with and deviated from conventional understandings of care practices, including overdose reversal and education, overdose supervision/care, and assisted injection.
CONCLUSION
The boundary between formal and informal harm reduction care is fluid. Women who use drugs engage in harm reduction across these borders with acts of care that align with or fill the gaps in current harm reduction services in order to meet the needs of drug-using communities, challenging negative stereotypes of women who use drugs. However, these caregiving practices can increase risks to care providers' physical, mental, and emotional health and wellness. Increased financial, social, and institutional supports, including safer supply, assisted injection, and community resources, are needed to better support women as they continue to engage in harm reduction care.
Identifiants
pubmed: 37055805
doi: 10.1186/s12954-023-00775-0
pii: 10.1186/s12954-023-00775-0
pmc: PMC10100181
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
49Subventions
Organisme : CIHR
ID : PJT-155943
Pays : Canada
Organisme : CIHR
ID : 183952
Pays : Canada
Informations de copyright
© 2023. The Author(s).
Références
Sociol Health Illn. 2019 Feb;41(2):427-443
pubmed: 30710415
Int J Drug Policy. 2019 Jun;68:109-116
pubmed: 30583823
J Acquir Immune Defic Syndr. 2015 Jun 1;69 Suppl 2:S176-81
pubmed: 25978485
Harm Reduct J. 2021 Jan 6;18(1):5
pubmed: 33407575
Int J Drug Policy. 2015 Dec;26(12):1198-206
pubmed: 26118796
Subst Use Misuse. 2012 Apr;47(5):491-501
pubmed: 22428817
Soc Sci Med. 2019 Mar;225:60-68
pubmed: 30798157
Harm Reduct J. 2021 Jan 6;18(1):1
pubmed: 33407500
Soc Stud Sci. 2015 Oct;45(5):625-41
pubmed: 26630814
Int J Drug Policy. 2020 Nov;85:102922
pubmed: 32911320
Am J Public Health. 2022 Apr;112(S2):S136-S139
pubmed: 35349317
Health (London). 2018 Jan;22(1):3-19
pubmed: 27491943
J Health Polit Policy Law. 2013 Apr;38(2):299-343
pubmed: 23262772
Harm Reduct J. 2015 Mar 07;12:6
pubmed: 25889492
Hum Organ. 2004 Sep;63(3):253-264
pubmed: 16685288
Crit Public Health. 2022;32(3):382-391
pubmed: 35812810
Int J Drug Policy. 2019 Apr;66:64-72
pubmed: 30708237
Harm Reduct J. 2020 Oct 19;17(1):78
pubmed: 33076931
Int J Drug Policy. 2020 Feb;76:102617
pubmed: 31838246
PLoS One. 2016 Jun 24;11(6):e0157805
pubmed: 27341206
Soc Sci Med. 2021 Jun;279:113986
pubmed: 33971445
Addiction. 2018 Dec;113(12):2261-2270
pubmed: 30211453
Int J Drug Policy. 2014 Jan;25(1):157-65
pubmed: 23932166
AIDS Behav. 2014 Mar;18(3):473-85
pubmed: 23797831
Soc Stud Sci. 2015 Oct;45(5):717-37
pubmed: 26630818
Int J Drug Policy. 2020 Apr;78:102733
pubmed: 32247720
J Subst Abuse Treat. 2022 Jan;132:108578
pubmed: 34373170
Soc Sci Med. 2021 Feb;270:113631
pubmed: 33418149
Int J Drug Policy. 2018 May;55:40-46
pubmed: 29501928
Harm Reduct J. 2017 May 18;14(1):28
pubmed: 28521829
Can J Nurs Res. 2002 Sep;34(2):81-94
pubmed: 12425002
Harm Reduct J. 2021 Feb 11;18(1):18
pubmed: 33573661
CMAJ. 2017 Aug 28;189(34):E1083-E1084
pubmed: 28847779
Harm Reduct J. 2020 May 7;17(1):27
pubmed: 32381011